D. E. Furst, A. A. Amato, ?. R. Iorga, K. Gajria, and A. W. Fernandes, Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan: Epidemiology of Idiopathic Inflammatory Myopathies, Muscle & Nerve. mai, vol.45, issue.5, pp.676-83, 2012.

A. Bohan and J. B. Peter, Polymyositis and Dermatomyositis, New England Journal of Medicine. 13 févr, vol.292, issue.7, pp.344-351, 1975.

O. Benveniste, W. Stenzel, and Y. Allenbach, Advances in serological diagnostics of inflammatory myopathies, Curr Opin Neurol, vol.29, issue.5, pp.662-73, 2016.

J. Schmidt, Current Classification and Management of Inflammatory Myopathies, Journal of Neuromuscular Diseases. 29 mai, vol.5, issue.2, pp.109-138, 2018.

V. Leclair and I. E. Lundberg, New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter, Current Rheumatology Reports, vol.20, issue.4, 2018.

L. A. Love, R. L. Leff, D. D. Fraser, I. N. Targoff, M. Dalakas et al., A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore), vol.70, pp.360-74, 1991.

Y. Troyanov, I. N. Targoff, J. Tremblay, J. Goulet, Y. Raymond et al., Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients, Medicine (Baltimore). juill, vol.84, issue.4, pp.231-280, 2005.

M. Bottai, A. Tjärnlund, G. Santoni, V. P. Werth, C. Pilkington et al., EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report. RMD Open, vol.3, p.507, 2017.

K. Mariampillai, B. Granger, D. Amelin, M. Guiguet, E. Hachulla et al., Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies, JAMA Neurology, issue.10, 2018.

D. Sur,

J. E. Hoogendijk, A. A. Amato, B. R. Lecky, E. H. Choy, I. E. Lundberg et al., 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, Neuromuscular Disorders. mai, vol.14, issue.5, pp.337-382, 2003.

C. P. Myosites, EMC -Traité Médecine AKOS, vol.6, pp.1-11, 2011.

I. Marie, P. Y. Hatron, D. S. , C. P. Mouthon, L. Menard et al., Short-Term and Long-Term Outcome of Anti-Jo1-Positive Patients with Anti-Ro52 Antibody, Seminars in Arthritis and Rheumatism. juin, vol.41, issue.6, pp.890-899, 2012.

R. W. Hallowell and S. K. Danoff, Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances. Current Opinion in Rheumatology, vol.26, pp.684-693, 2014.

A. Selva-o'callaghan, M. Labrador-horrillo, X. Muñoz-gall, X. Martínez-gomez, J. Majó-masferrer et al., Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients, Lupus. juill, vol.14, issue.7, pp.534-576, 2005.

R. Gupta, S. A. Wayangankar, I. N. Targoff, and T. A. Hennebry, Clinical cardiac involvement in idiopathic inflammatory myopathies: A systematic review, International Journal of Cardiology. mai, vol.148, issue.3, pp.261-70, 2011.

B. B. Antiochos, L. A. Brown, Z. Li, T. D. Tosteson, R. L. Wortmann et al., Malignancy Is Associated with Dermatomyositis But Not Polymyositis in Northern New England, USA, The Journal of Rheumatology. 1 déc, vol.36, issue.12, pp.2704-2714, 2009.

A. Selva-o?callaghan, E. Trallero-araguás, J. M. Grau-junyent, and M. Labrador-horrillo, Malignancy and myositis: novel autoantibodies and new insights: Current Opinion in Rheumatology, vol.22, pp.627-659, 2010.

Z. A. Zahr and A. N. Baer, Malignancy in Myositis, Current Rheumatology Reports. juin, vol.13, issue.3, pp.208-223, 2011.
DOI : 10.1007/s11926-011-0169-7

J. T. Kissel, J. R. Mendell, and K. W. Rammohan, Microvascular Deposition of Complement Membrane Attack Complex in Dermatomyositis, New England Journal of Medicine. 6 févr, vol.314, issue.6, pp.329-363, 1986.

M. Fujimoto, R. Watanabe, Y. Ishitsuka, and N. Okiyama, Recent advances in dermatomyositis-specific autoantibodies: Current Opinion in Rheumatology, vol.28, pp.636-680, 2016.

Y. Allenbach, O. Benveniste, H. Goebel, and W. Stenzel, Integrated classification of inflammatory myopathies, Neuropathology and Applied Neurobiology. févr, vol.43, issue.1, pp.62-81, 2017.

J. C. Hall, L. Casciola-rosen, L. Samedy, J. Werner, K. Owoyemi et al., AntiMelanoma Differentiation-Associated Protein 5-Associated Dermatomyositis: Expanding the Clinical Spectrum: Clinical Features of Anti-MDA-5-Positive Patients, Arthritis Care & Research. août, vol.65, issue.8, pp.1307-1322, 2013.

K. Kaji, M. Fujimoto, M. Hasegawa, M. Kondo, Y. Saito et al., Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy, Rheumatology. 1 janv, vol.46, issue.1, pp.25-33, 2007.

H. Gunawardena, L. R. Wedderburn, H. Chinoy, Z. E. Betteridge, J. North et al., Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis, Arthritis & Rheumatism. juin, vol.60, issue.6, pp.1807-1821, 2009.

A. Rigolet, L. Musset, O. Dubourg, T. Maisonobe, P. Grenier et al., Inflammatory Myopathies With Anti-Ku Antibodies: A Prognosis Dependent on Associated Lung Disease, Medicine. mars, vol.91, issue.2, pp.95-102, 2012.

Y. Hamaguchi, M. Fujimoto, T. Matsushita, K. Kaji, K. Komura et al., Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome, PLoS ONE, vol.8, issue.4, p.60442, 2013.

J. Lega, N. Fabien, Q. Reynaud, I. Durieu, S. Durupt et al., The clinical phenotype associated with myositis-specific and associated autoantibodies: A metaanalysis revisiting the so-called antisynthetase syndrome, Autoimmunity Reviews. sept, vol.13, issue.9, pp.883-91, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02046821

C. Marguerie, C. C. Bunn, H. L. Beynon, R. M. Bernstein, J. M. Hughes et al., Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes, Q J Med. oct, vol.77, issue.282, pp.1019-1057, 1990.

A. Uruha, S. Suzuki, N. Suzuki, and I. Nishino, Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1, Brain. sept, vol.139, issue.9, pp.50-50, 2016.

L. Mescam-mancini, Y. Allenbach, B. Hervier, H. Devilliers, K. Mariampillay et al., Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis, Brain. sept, vol.138, pp.2485-92, 2015.

B. Hervier, H. Devilliers, R. Stanciu, A. Meyer, Y. Uzunhan et al., Hierarchical cluster and survival analyses of antisynthetase syndrome: Phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity, Autoimmunity Reviews. déc, vol.12, issue.2, pp.210-217, 2012.

R. Aggarwal, E. Cassidy, N. Fertig, D. C. Koontz, M. Lucas et al., Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients, Annals of the Rheumatic Diseases. janv, vol.73, issue.1, pp.227-259, 2014.

Y. Allenbach, L. Drouot, A. Rigolet, J. L. Charuel, F. Jouen et al., Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin, Medicine. mai, vol.93, issue.3, pp.150-157, 2014.

Y. Allenbach, J. Keraen, A. Bouvier, V. Jooste, N. Champtiaux et al., High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody, Brain. août, vol.139, issue.8, pp.2131-2136, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01409979

M. Van-der-meulen, I. M. Bronner, J. E. Hoogendijk, H. Burger, W. J. Van-venrooij et al., Polymyositis: an overdiagnosed entity, Neurology. 12 août, vol.61, issue.3, pp.316-337, 2003.

A. A. Amato and R. C. Griggs, Unicorns, dragons, polymyositis, and other mythological beasts, Neurology. 12 août, vol.61, issue.3, pp.288-297, 2003.

O. Benveniste, O. Dubourg, and S. Herson,

, Rev Med Interne. sept, vol.28, issue.9, pp.603-615, 2007.

O. Benveniste, M. Guiguet, J. Freebody, O. Dubourg, W. Squier et al., Longterm observational study of sporadic inclusion body myositis, Brain, vol.134, issue.11, pp.3176-84, 2011.

M. R. Rose, . Enmc-ibm-working, and . Group, 188th ENMC International Workshop: Inclusion Body Myositis, vol.23, pp.1044-55, 2011.

N. A. Goyal, T. M. Cash, U. Alam, S. Enam, P. Tierney et al., Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement, Neurosurgery & Psychiatry. avr, vol.87, issue.4, pp.373-381, 2016.

M. Jammal, A. Kettaneh, J. Cabane, K. Tiev, and C. Toledano, Capillaroscopie périunguéale : une évaluation simple et fiable de toute pathologie de la microcirculation. La Revue de Médecine Interne, sept, vol.36, issue.9, pp.603-615, 2015.

, Collège des enseignants de médecine vasculaire (France), 2013.

, Outcomes, rates and predictors of transition of isolated Raynaud's phenomenon: a systematic review and meta-analysis. Swiss Medical Weekly [Internet]. 30 sept, p.147, 2017.

P. Legendre and L. Mouthon, Sclérodermie systémique, EMC -AKOS (Traité de Médecine), vol.11, issue.1, pp.1-10, 2016.

F. Van-den-hoogen, D. Khanna, J. Fransen, S. R. Johnson, M. Baron et al., Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative: ACR/EULAR Classification Criteria for SSc. Arthritis & Rheumatism, vol.65, pp.2737-2784, 2013.

M. Cutolo, A. Sulli, C. Pizzorni, and S. Accardo, Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis, J Rheumatol. janv, vol.27, issue.1, pp.155-60, 2000.

S. Soulaidopoulos, E. Triantafyllidou, A. Garyfallos, G. D. Kitas, and T. Dimitroulas, The role of nailfold capillaroscopy in the assessment of internal organ involvement in systemic sclerosis: A critical review, Autoimmunity Reviews. août, vol.16, issue.8, pp.787-95, 2017.

V. Smith, S. Decuman, A. Sulli, C. Bonroy, Y. Piettte et al., Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Annals of the Rheumatic Diseases, vol.71, pp.1636-1645, 2012.

P. Caramaschi, S. Canestrini, N. Martinelli, A. Volpe, S. Pieropan et al., Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity, Rheumatology. 27 août, vol.46, issue.10, pp.1566-1575, 2007.

F. Ingegnoli, I. Ardoino, P. Boracchi, M. Cutolo, P. Airò et al., Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database. Microvascular Research, vol.89, pp.122-130, 2013.

P. Lee, F. Y. Leung, C. Alderdice, and S. K. Armstrong, Nailfold capillary microscopy in the connective tissue diseases: a semiquantitative assessment, J Rheumatol. déc, vol.10, issue.6, pp.930-938, 1983.

H. R. Maricq, A. B. Weinberger, and E. C. Leroy, Early detection of scleroderma-spectrum disorders by in vivo capillary microscopy: a prospective study of patients with Raynaud's phenomenon, J Rheumatol. avr, vol.9, issue.2, pp.289-91, 1982.

H. R. Maricq, F. E. Harper, M. M. Khan, E. M. Tan, and E. C. Leroy, Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease, Clin Exp Rheumatol. sept, vol.1, issue.3, pp.195-205, 1983.

M. Cutolo, A. Sulli, M. E. Secchi, M. Olivieri, and C. Pizzorni, The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases, Best Pract Res Clin Rheumatol. déc, vol.21, issue.6, pp.1093-108, 2007.

N. Szabo, Z. Csiki, A. Szanto, K. Danko, P. Szodoray et al., Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud's and Sjögren's syndrome and poly/dermatomyositis, Scandinavian Journal of Rheumatology. janv, vol.37, issue.1, pp.23-32, 2008.

C. Bertolazzi, M. Cutolo, V. Smith, and M. Gutierrez, State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis, Seminars in Arthritis and Rheumatism. déc, vol.47, issue.3, pp.432-476, 2017.

H. R. Maricq and E. C. Leroy, Patterns of finger capillary abnormalities in connective tissue disease by « wide-field » microscopy. Arthritis Rheum, vol.16, pp.619-647, 1973.

H. R. Maricq, G. Spencer-green, and E. C. Leroy, Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis, Am J Med. déc, vol.61, issue.6, pp.862-70, 1976.

T. Matsushita, M. Hasegawa, M. Fujimoto, Y. Hamaguchi, K. Komura et al., Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis, J Rheumatol. mai, vol.34, issue.5, pp.1012-1020, 2007.

L. K. Mercer, T. L. Moore, H. Chinoy, A. K. Murray, A. Vail et al., Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy, Rheumatology (Oxford). sept, vol.49, issue.9, pp.1699-705, 2010.

S. Kubo, Y. Todoroki, S. Nakayamada, K. Nakano, M. Satoh et al., Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies, Rheumatology (Oxford). 28 août, 2018.

S. Pavlov-dolijanovic, N. S. Damjanov, R. M. Stojanovic, V. Stupar, N. Z. Stanisavljevic et al., Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon. Rheumatol Int, vol.32, pp.3039-3084, 2012.

A. Manfredi, M. Sebastiani, F. Campomori, N. Pipitone, D. Giuggioli et al., Nailfold Videocapillaroscopy Alterations in Dermatomyositis and Systemic Sclerosis: Toward Identification of a Specific Pattern, The Journal of Rheumatology. 1 août, vol.43, issue.8, pp.1575-80, 2016.

R. Bergman, L. Sharony, D. Schapira, M. A. Nahir, and A. Balbir-gurman, The handheld dermatoscope as a nail-fold capillaroscopic instrument, Arch Dermatol. août, vol.139, issue.8, pp.1027-1057, 2003.

R. De-angelis, M. Cutolo, M. Gutierrez, C. Bertolazzi, F. Salaffi et al., Different microvascular involvement in dermatomyositis and systemic sclerosis. A preliminary study by a tight videocapillaroscopic assessment, Clin Exp Rheumatol. avr, vol.30, issue.2, pp.67-70, 2012.

A. Manfredi, M. Sebastiani, G. Cassone, N. Pipitone, D. Giuggioli et al., Nailfold capillaroscopic changes in dermatomyositis and polymyositis, Clinical Rheumatology. févr, vol.34, issue.2, pp.279-84, 2015.

C. Bertolazzi, M. Cutolo, V. Smith, and M. Gutierrez, State of the art on nailfold capillaroscopy in dermatomyositis and polymyositis, Seminars in Arthritis and Rheumatism. déc, vol.47, issue.3, pp.432-476, 2017.

A. Selva-o'callaghan, V. Fonollosa-pla, E. Trallero-araguás, X. Martínez-gómez, C. P. Simeon-aznar et al., Nailfold Capillary Microscopy in Adults with Inflammatory Myopathy, Seminars in Arthritis and Rheumatism. avr, vol.39, issue.5, pp.398-404, 2010.